HSHemangi B. Shah

Hemangi B. Shah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hemangi B. Shah has a total of 12 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies

    by Hemangi B. Shah, Kenneth Smith, Edgar J. Scott, Jason L. Larabee, Judith A. James, Jimmy D. Ballard, Mark L. Lang

    Clostridioides difficile is a leading cause of nosocomial infection responsible for significant morbidity and mortality with limited options for therapy. Secreted C . difficile toxin B (TcdB) is a major contributor to disease pathology, and select TcdB-specific Abs may protect against disease recurrence. However, the high frequency of recurrence suggests that the memory B cell response, essential for new Ab production following C . difficile reexposure, is insufficient. We therefore isolated TcdB-specific memory B cells from individuals with a history of C . difficile infection and performed single-cell deep sequencing of their Ab genes. Herein, we report that TcdB-specific memory B cell–encoded antibodies showed somatic hypermutation but displayed limited isotype class switch. Memory B cell–encoded mAb generated from the gene sequences revealed low to moderate affinity for TcdB and a limited ability to neutralize TcdB. These findings indicate that memory B cells are an important factor in C . difficile disease recurrence.


  • Open Access

    Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires

    by Hemangi B. Shah, Kenneth Smith, Jonathan D. Wren, Carol F. Webb, Jimmy D. Ballard, Rebecka L. Bourn, Judith A. James, Mark L. Lang

    Memory B cells that are generated during an infection or following vaccination act as sentinels to guard against future infections. Upon repeat antigen exposure memory B cells differentiate into new antibody-secreting plasma cells to provide rapid and sustained protection. Some pathogens evade or suppress the humoral immune system, or induce memory B cells with a diminished ability to differentiate into new plasma cells. This leaves the host vulnerable to chronic or recurrent infections. Single cell approaches coupled with next generation antibody gene sequencing facilitate a detailed analysis of the pathogen-specific memory B cell repertoire. Monoclonal antibodies that are generated from antibody gene sequences allow a functional analysis of the repertoire. This review discusses what has been learned thus far from analysis of diverse pathogen-specific memory B cell compartments and describes major differences in their repertoires. Such information may illuminate ways to advance the goal of improving vaccine and therapeutic antibody design.